LY83583 (Standard)

Overview

LY83583 (Standard) is the analytical standard of LY83583 ( HY-W013386 ). This product is intended for research and analytical applications. LY83583 is inhibitor of soluble guanylate cyclase ( sGC ) with the ability to target the cGMP signaling pathway. LY83583 inhibits the kinase activity-related proliferation of tumor cells by inducing the Cdk inhibitor p21 . LY83583 can be used for the study of cancers (colorectal cancer , breast cancer and melanoma) and cardiovascular disease .

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Guanylate Cyclase

Product Information

• Catalog No.: HY-W013386R
• CAS No.: 91300-60-6
• Molecular Formula: C15H10N2O2
• Molecular Weight: 250.26
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source